Cite
MLA Citation
Arun Rajan et al.. “Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.” Journal for immunotherapy of cancer, vol. 7, no. 1, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100144511472.0x000019